# Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period

> **NCT04452188** · NA · COMPLETED · sponsor: **University of Michigan** · enrollment: 29 (actual)

## Conditions studied

- Hypoplastic Left Heart Syndrome
- Total Anomalous Pulmonary Venous Return
- Truncus Arteriosus
- Pulmonary Atresia With Ventricular Septal Defect
- Transposition of the Great Arteries
- Double Outlet Right Ventricle, Subpulmonary VSD
- Tetralogy of Fallot
- Double Outlet Right Ventricle With Subaortic Ventricular Septal Defect and Pulmonary Stenosis
- Cardiopulmonary Bypass

## Interventions

- **OTHER:** Normoxia (with controlled re-oxygenation)
- **OTHER:** Standard of care ventilation

## Key facts

- **NCT ID:** NCT04452188
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-18
- **Primary completion:** 2023-04-20
- **Final completion:** 2023-04-20
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2024-06-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04452188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04452188, "Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04452188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*